Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 28, 2015; 21(48): 13418-13431
Published online Dec 28, 2015. doi: 10.3748/wjg.v21.i48.13418
Published online Dec 28, 2015. doi: 10.3748/wjg.v21.i48.13418
Figure 3 Molecular mechanism of hepatolithiasis-associated cholangiocarcinoma.
HL-CCA: hepatolithiasis-associated cholangiocarcinoma; NF-κB: Nuclear factor kappa-B; EGFR: Epidermal growth factor receptor; PGE2: Prostaglandin E2; COX-2: Cyclooxygenase-2; IPNB: Intraductal papillary neoplasm of the bile duct; BilIN: Biliary intraepithelial neoplasia.
- Citation: Kim HJ, Kim JS, Joo MK, Lee BJ, Kim JH, Yeon JE, Park JJ, Byun KS, Bak YT. Hepatolithiasis and intrahepatic cholangiocarcinoma: A review. World J Gastroenterol 2015; 21(48): 13418-13431
- URL: https://www.wjgnet.com/1007-9327/full/v21/i48/13418.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i48.13418